Presentations.AI Launches White-Label AI Presentation Generator and Editable PowerPoint API for SaaS Companies, Agencies and AI Agents at $0.10 Per Slide With a 50% Launch Discount 
SAP Helps CHKP Group Connect Online and Offline Retail to Deliver Personalised Experiences at AV Life and FOTOMAX 
Vietnam’s E-Commerce Grew 44% in 2026. Its Parcel Count Grew 13.7%, and the Gap Is the Story 
MicroVision Expands Collaboration with FieldAI Across Government and Industrial Autonomous Systems Programs 
Results for Third Quarter Ending 30 September 2026 BNP Paribas Hires Carl Riccadonna as Chief U.S. Economist
Key Hire Demonstrates Bank’s Mission to Strengthen Americas Client Franchise NEW YORK–(BUSINESS WIRE)–BNP Paribas, the…
Energy Dome Wins Prestigious BloombergNEF Pioneers 2022 Low-Carbon Technology Competition
Energy Dome’s long-duration energy storage technology is recognized for its ability to decarbonize the economy…
Kyruus and Hyro Form Partnership to Help Healthcare Organizations Boost Online Conversion Through Digital Self-Service
Partnership will Enable Healthcare Organizations to Enhance Conversational AI Experiences with Robust Provider Search and…
Kalao integrates Ramp to drive the mainstream adoption of NFTs
London, UK: 14 April 2022 – Payments infrastructure provider Ramp has partnered with Kalao, a…
Longeveron to Present at Longevity Leaders World Congress; Latinos and Alzheimer’s Symposium; International Frailty and Sarcopenia Research Conference
April events to highlight Longeveron’s commitment to developing cell therapeutics for chronic aging related diseases….
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
Q3 Net loss per share of $0.01 vs. a net loss of $0.18 per share…
Agios Announces Publication of Phase 3 ACTIVATE Study in New England Journal of Medicine Demonstrating Benefits of PYRUKYND® (mitapivat) for Adults with Pyruvate Kinase Deficiency
– In Adults with Pyruvate Kinase (PK) Deficiency Who Are Not Regularly Transfused, PYRUKYND® Significantly…
Junshi Biosciences and Coherus Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
SHANGHAI, China and REDWOOD CITY, Calif., April 14, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences…
Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual Meeting
Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients was well…
Coherus and Junshi Biosciences Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
REDWOOD CITY, Calif., and SHANGHAI, China, April 14, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”,…
Vaxart to Present at World Vaccine Congress Washington 2022 on April 20
SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today…
Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
BOSTON, April 14, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…
Akoya to Report First Quarter 2022 Financial Results on May 5th, 2022
MARLBOROUGH, Mass., April 14, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Allogene Therapeutics Unveils Cell Forge 1, a Uniquely Designed Manufacturing Facility to Deliver AlloCAR T™ Products
Interactive Experience Designed to Showcase the 136,000sf cGMP Facility Located in Newark, California Cell Forge…
AGTC to Present at Cell & Gene Meeting on the Mediterranean
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 14, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Cocrystal Pharma to Present at the Noble Capital Markets’ NobleCon18 Conference
BOTHELL, Wash., April 14, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James…
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022
BUFFALO, N.Y., April 14, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
Cidara Therapeutics and Mundipharma to Present Results from Global Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and/or Invasive Candidiasis at ECCMID 2022
SAN DIEGO and CAMBRIDGE, United Kingdom, April 14, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc….
Reflect Scientific’s Cryometrix Brand Solvent Chillers Off to a Hot Start
OREM, Utah, April 14, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider…
Sera Labs Inc. Products Now Available at Walmart, Bed Bath & Beyond, CVS and Target.com
LOS ANGELES, April 14, 2022 (GLOBE NEWSWIRE) — Sera Labs, a wholly subsidiary of CURE…